Inhibition of ATP‐Sensitive Potassium Channels in Cardiac Myocytes by the Novel Class III Antiarrhythmic Agent MS‐551
- 1 July 1995
- journal article
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 77 (1) , 65-70
- https://doi.org/10.1111/j.1600-0773.1995.tb01915.x
Abstract
The novel class III antiarrhythmic agent, MS‐551, has recently been shown to attenuate the decrease in ventricular effective refractory period and to prevent the subsequent ventricular fibrillation induced by pinacidil and hypoxia in isolated perfused rabbit hearts (Friedrichs et al. 1994). We studied the effects of MS‐551 on single ATP‐sensitive potassium channels in isolated rabbit ventricular myocytes using standard patch‐clamp methods. MS‐551 in the range from 1 μM to 100 μM produced a concentration‐dependent reduction of the open probability of the ATP‐sensitive potassium channel, with an apparent ED50 of 30 μM. This reduced channel activity was due to a smaller number of channel openings per unit time, and the average duration of each opening of the channel was unaffected. This property of MS‐551 is likely to be of most significance in ischaemic tissue, where the ATP‐sensitive channels are thought to carry the predominant current that shortens the duration of the action potential.Keywords
This publication has 31 references indexed in Scilit:
- Antiarrhythmic Agent, MS-551, Protects Against Pinacidil + Hypoxia-Induced Ventricular Fibrillation in Langendorff-Perfused Rabbit Isolated HeartJournal of Cardiovascular Pharmacology, 1994
- RP 58866 and Its Active Enantiomer RP 62719 (Terikalant)Journal of Cardiovascular Pharmacology, 1992
- Role of ATP dependent potassium channels in myocardial ischaemiaCardiovascular Research, 1992
- Blockade of 2,4-dinitrophenol induced ATP sensitive potassium current in guinea pig ventricular myocytes by class I antiarrhythmic drugsCardiovascular Research, 1992
- Development of Class III Antiarrhythmic AgentsJournal of Cardiovascular Pharmacology, 1992
- The ATP-Sensitive K+ Channel.The Japanese Journal of Physiology, 1991
- Antiarrhythmic effect and haemodynamic properties of MS-551, a new class III antiarrhythmic agent, in anaesthetized dogsEuropean Journal of Pharmacology, 1990
- Cellular electrophysiological effects of MS-551, a new class III antiarrhythmic agent, in various cardiac tissues: comparison with D-sotalolEuropean Journal of Pharmacology, 1990
- Influence of ATP-sensitive potassium channel modulators on ischemia-induced fibrillation in isolated rat heartsJournal of Molecular and Cellular Cardiology, 1989
- Editorial: Modification of class III anti-arrhythmic activity in abnormal myocardiumCardiovascular Research, 1988